Camelot Portfolios’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,500
Closed -$276K 203
2026
Q1
$276K Hold
19,500
0.2% 151
2025
Q4
$276K Hold
19,500
0.17% 145
2025
Q3
$288K Hold
19,500
0.17% 148
2025
Q2
$295K Hold
19,500
0.18% 150
2025
Q1
$281K Buy
19,500
+1,000
+5% +$15.3K 0.17% 152
2024
Q4
$280K Sell
18,500
-5,000
-21% -$80.4K 0.3% 99
2024
Q3
$387K Sell
23,500
-1,000
-4% -$16.4K 0.38% 80
2024
Q2
$402K Buy
24,500
+1,000
+4% +$16.1K 0.23% 104
2024
Q1
$392K Sell
23,500
-1,000
-4% -$15.5K 0.38% 80
2023
Q4
$366K Buy
24,500
+1,000
+4% +$14.5K 0.22% 120
2023
Q3
$341K Sell
23,500
-3,000
-11% -$44.9K 0.33% 89
2023
Q2
$404K Hold
26,500
0.25% 111
2023
Q1
$401K Buy
26,500
+1,000
+4% +$14.8K 0.28% 104
2022
Q4
$354K Buy
+25,500
New +$360K 0.26% 114

Other funds holding BCAT

Camelot Portfolios's BCAT Position: Q2 2026 in Review

Camelot Portfolios sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2026, closing a stake of 19,500 shares — an estimated $276K sold.

Camelot Portfolios first reported a position in BCAT in Q4 2022 and held it in 14 quarters. The position peaked at $404K in Q2 2023. 12 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • Camelot Portfolios reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2026 after selling out during the quarter.
  • Camelot Portfolios sold 19,500 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $276K.
  • Camelot Portfolios first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 14 quarters.
  • Camelot Portfolios's BlackRock Capital Allocation Term Trust position peaked at $404K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.